Alkermes plc. (ALKS) insider trading

Insider

Date

Role

Action

Shares

Price

Amount

Craig C. Hopkinson

1 Sep 2026

EVP R&D, Chief Medical Officer

Sold after exercise

9,000

$46.99

$422.87K

Craig C. Hopkinson

3 Aug 2026

EVP R&D, Chief Medical Officer

Sold after exercise

9,000

$48.58

$437.22K

nancy lynn MD snyderman

3 Aug 2026

Director

Sold after exercise

44,472

$50.35

$2.24M

Craig C. Hopkinson

1 Jul 2026

EVP R&D, Chief Medical Officer

Sold after exercise

700

$52.13

$36.49K

Craig C. Hopkinson

1 Jul 2026

EVP R&D, Chief Medical Officer

Sold after exercise

8,300

$51.46

$427.13K

Craig C. Hopkinson

1 Jun 2026

EVP R&D, Chief Medical Officer

Sold after exercise

9,000

$41.67

$375.04K

Samuel Joseph Parisi

29 May 2026

VP, Finance (Interim PAO)

Sold after exercise

16,217

$42.36

$687.01K

Craig C. Hopkinson

1 May 2026

EVP R&D, Chief Medical Officer

Sold after exercise

9,000

$33.40

$300.56K

Craig C. Hopkinson

1 Apr 2026

EVP R&D, Chief Medical Officer

Sold after exercise

9,000

$35.51

$319.60K

Craig C. Hopkinson

2 Mar 2026

EVP R&D, Chief Medical Officer

Sold after exercise

9,000

$29.72

$267.49K

Shane Cooke

2 Feb 2026

Director

Sold after exercise

32,113

$34.78

$1.12M

Shane Cooke

2 Feb 2026

Director

Sold after exercise

29,087

$34.34

$998.80K

Craig C. Hopkinson

2 Feb 2026

EVP R&D, Chief Medical Officer

Sold after exercise

4,000

$33.54

$134.16K

Craig C. Hopkinson

2 Feb 2026

EVP R&D, Chief Medical Officer

Sold after exercise

5,000

$34.24

$171.22K

Craig C. Hopkinson

8 Jan 2026

EVP R&D, Chief Medical Officer

Sold after exercise

5,000

$30.00

$150.01K

Craig C. Hopkinson

3 Dec 2025

EVP R&D, Chief Medical Officer

Sold after exercise

3,748

$30.00

$112.45K

Alkermes plc.

What the insiders did Scheduled selling only

Individual transactions

What was left out